Fact CheckerSign in

NCT07570576Not yet recruiting

Front-of-package Warning Labels for Sugar Content in Sugar-sweetened Beverages

Front-of-package Warning Labels for Sugar Content in Sugar-sweetened Beverages: An Online Randomized Experiment

Source: ClinicalTrials.gov · Last updated 12 May 2026

Brief summary (registry, in English)

The goal of this online randomized trial is to examine the effectiveness of Front-of-package (FOP) warning labels for added sugar content on the intent-to-purchases of SSBs in an affluent Asian setting. We hypothesize the FOP warning labels are significantly associated with a reduction of consumers' purchase intention of sugar-sweetened beverages (SSBs).

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
2800 (estimated)
First submitted
30 Apr 2026
Start date
May 2026
Primary completion date
Apr 2027
Lead sponsor
Chinese University of Hong Kong
Diseases
Obesity
NCT number
NCT07570576

What you commit to

  • Study type: Interventional
  • Planned participants: 2800
  • From May 2026 to the primary completion date, Apr 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Refuse to provide informed consent
  • Failing an attention check, defined as an incorrect response to a multiple-choice question asking "What month is it currently?",
  • Implausibly short completion times, defined as completing the survey in less than 133 seconds, which corresponds to half of the median completion time observed in pilot data

Who the study is looking for

  • Hong Kong residents aged 18 years or older and be able to understand either English or Chinese

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.